Forskningsresultat per år
Forskningsresultat per år
Personlig profil
Vetenskapsgrenar
- 317 Farmaci
- 3112 Neurovetenskaper
Internationellt och inhemskt samarbete
Publikationer och projekt inom de senaste fem åren.
-
ARG1-expressing microglia show a distinct molecular signature and modulate postnatal development and function of the mouse brain
Stratoulias, V., Ruiz, R., Kanatani, S., Osman, A. M., Keane, L., Armengol, J. A., Rodriguez-Moreno, A., Murgoci, A-N., Garcia-Dominguez, I., Alonso-Bellido, I., Ibanez, F. G., Picard, K., Vazquez-Cabrera, G., Posada-Perez, M., Vernoux, N., Tejera, D., Grabert, K., Cheray, M., Gonzalez-Rodriguez, P., Perez-Villegas, E. M., & 12 andra, 11 maj 2023, I: Nature Neuroscience. 39 s.Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review
Öppen tillgång -
Augmenting hematoma-scavenging capacity of innate immune cells by CDNF reduces brain injury and promotes functional recovery after intracerebral hemorrhage
Tseng, K-Y., Stratoulias, V., Hu, W-F., Wu, J-S., Wang, V., Chen, Y-H., Seelbach, A., Huttunen, H. J., Kulesskaya, N., Pang, C-Y., Chou, J-L., Lindahl, M., Saarma, M., Huang, L-C., Airavaara, M. & Liew, H-K., 15 feb. 2023, I: Cell Death and Disease. 14, 2, 20 s., 128.Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review
Öppen tillgångFil -
Protective mechanisms by glial cell line-derived neurotrophic factor and cerebral dopamine neurotrophic factor against the ?-synuclein accumulation in Parkinson?s disease
Er, S. & Airavaara, M., 16 feb. 2023, I: Biochemical Society Transactions. 51, 1, s. 245-257 13 s.Forskningsoutput: Tidskriftsbidrag › Översiktsartikel › Peer review
-
A novel variant in SMG9 causes intellectual disability, confirming a role for nonsense-mediated decay components in neurocognitive development
Rahikkala, E., Urpa, L., Ghimire, B., Topa, H., Kurki, M., Koskela, M., Airavaara, M., Hämäläinen, E., Pylkäs, K., Körkkö, J., Savolainen, H., Suoranta, A., Bertoli-Avella, A., Rolfs, A., Mattila, P., Daly, M., Palotie, A., Pietiläinen, O., Moilanen, J. & Kuismin, O., maj 2022, I: European Journal of Human Genetics. 30, s. 619-627 9 s.Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review
Öppen tillgångFil -
Cell Culture Media, Unlike the Presence of Insulin, Affect alpha-Synuclein Aggregation in Dopaminergic Neurons
Hlushchuk, I., Barut, J., Airavaara, M., Luk, K., Domanskyi, A. & Chmielarz, P., apr. 2022, I: Biomolecules. 12, 4, 15 s., 563.Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review
Öppen tillgångFil
-
BF R2B KAJO 23-24 Airavaara
Airavaara, M., Noutere, J. B. & STRATOULIAS, V.
Innovaatiorahoituskeskus Business Finland
01/01/2023 → 31/12/2024
Projekt: Business Finland
-
Yliopiston profilointi7 -InterEarth -ML
Airavaara, M., Heiskanen, J., Huiskonen, J., Hyvärinen, M., Kulmala, M., Kulmala, M., Mervaala, E., Primmer, C., Sironen, T., Toivonen, R., Auvinen, P., Eronen, J. T., Heikinheimo, A., Holopainen, M., Hyytiäinen, K., Karhu, K., Korpela, K., Lewandowska, A., Lindroos, M., Lintunen, A., Siven, M., Thomas, D. N., Tiira, T., Uimari, P., Vainio, A., Varjosalo, M. & Vartiainen, M.
Finlands Akademi, Suomen Akatemia Projektilaskutus
01/01/2023 → 31/12/2028
Projekt: Finlands Akademi: Stärkande av universitetens profilering (PROFI)
-
Gliasolulinjaperäisen hermokasvutekijän merkitys alkoholihimossa
01/01/2014 → …
Projekt: Forskningsprojekt
-
Additional experiments with CDNF for the with 6-OHDA model Parkinson’s Research,
03/06/2013 → …
Projekt: Forskningsprojekt
-
Effects of Recombinant CDNF Protein in Alpha-synuclein Model of Parkinson’s Disease in Pre-Clinical Models
01/01/2013 → …
Projekt: Forskningsprojekt
Priser
-
Innoopeli Prize 2022
Hanski, Leena (!!Recipient), Airavaara, Mikko (!!Recipient), Bunker, Alex Edwin (!!Recipient), Holmström, Anna-Riia (!!Recipient), Jeltsch, Michael (!!Recipient), Rantamäki, Tomi (!!Recipient), Sikanen, Tiina (!!Recipient), Voutilainen, Merja (!!Recipient), Lindstedt, Hanna Pauliina (!!Recipient), Kuusinen, Aarni (!!Recipient), Haapalainen, Joonatan Thomas Viljami (!!Recipient), Hintikka, Simo Johannes (!!Recipient), Baramaki, Iman (!!Recipient) & Kaukiainen, Kaisa (!!Recipient), 9 dec. 2022
Pris: Pris och hedersbetygelser
Tidningsurklipp
-
Announcement: A study showing CDNF's therapeutic effects in alpha-synuclein-based animal models published
Henri Huttunen & Mikko Airavaara
20/05/2021
2 objekt av Mediabevakning
Press/media: !!Press / Media
-
Herantis Pharma: Announcement: A study showing CDNF's therapeutic effects in alpha-synuclein-based animal models published
Henri Huttunen & Mikko Airavaara
20/05/2021
1 objekt av Mediabevakning
Press/media: !!Press / Media
-
FinPharma kick-off webinar 21 October 2020
Tatu Lajunen, Michael Jeltsch, Tiina Sikanen, Mikko Airavaara & Jari Yli-Kauhaluoma
07/09/2020
1 objekt av Mediabevakning
Press/media: !!Press / Media
-
Australia Patent: Helsingin Yliopisto Files Application for 'C-terminal CDNF and manf fragments, pharmaceutical compositions comprising same and uses thereof'
Maria Lindahl, Merja Voutilainen & Mikko Airavaara
01/12/2019
1 objekt av Mediabevakning
Press/media: !!Press / Media
-
WIPO PUBLISHES PATENT OF HELSINGIN YLIOPISTO FOR "C-TERMINAL CDNF AND MANF FRAGMENTS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME AND USES THEREOF" (FINNISH INVENTORS)
Maria Lindahl, Merja Voutilainen & Mikko Airavaara
13/11/2018
1 objekt av Mediabevakning
Press/media: !!Press / Media